Double blind trial with suloctidil, a new vasoactive agent, in elderly patients with psycho-organic brain syndrome.
D000368:Aged; D001928:Brain Diseases, Metabolic / Q000188:drug therapy*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004341:Drug Evaluation; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011412:Propanolamines / Q000627:therapeutic use*; D011594:Psychometrics; D013577:Syndrome; D014665:Vasodilator Agents / Q000627:therapeutic use*
D011412:Propanolamines; D014665:Vasodilator Agents